All In MedTech

Device Trial Radar · NCT07100834

Pulsed ElectRic FiEld Versus Cryoballoon for PAF

Pulsed ElectRic FiEld Versus Cryoballoon to Treat Paroxysmal Atrial Fibrillation (PERFECT-PAF) Randomized Trial

Last checked: Nov 19, 2026Latest source record: Aug 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 269 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

269

Actual

Start

Sep 27, 2023

Primary completion

May 30, 2024

Study completion Jun 30, 2025

Sponsor

Lead sponsor
Universitair Ziekenhuis BrusselAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 3, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study has been designed to compare the success rate of two different commercially available ablation technologies, namely PFA and Cryo. Both technologies are standard of care ablation procedures. An ablation is a procedure where a small piece of tissue of the heart, that. causes an irregular heartbeat, is heated or frozen (cryo-ablation) using a special type of catheter. Once you have signed this consent to take part of the study, you will be randomly assigned to one of the two ablation strategies (PFA versus Cryo). Randomization is a method that helps prevent any possible influence of human choices on clinical results and improve objectivity in research. The day of the procedure you will be undergo AF catheter ablation via either PFA or Cryo based on the results of randomization. Although both devices that will be used in this study are commercially approved, assessing the incidence of arrhythmia recurrence after ablation during follow-up is considered the investigational portion of the study. "Investigational" means that recurrence data will be collected after the cardiac ablation procedure and compared amongst the two standard of care ablation methods used to treat AF. This study will investigate how well PFA and Cryo work to prevent recurrences of atrial arrhythmias and if there are any differences between the two technologies

Conditions

  • Atril Fibrillation
  • Cardiac Arrhythmia
  • Paroxysmal Atrial Fibrillation (PAF)

Interventions

  • Single-Shot Pulsed Field Ablation (FARAPULSE™ Pulsed Field Ablation System)Device

    The FARAPULSE™ Pulsed Field Ablation System (Boston Scientific, Inc.) is a CE-marked system consisting of the FARASTAR™ Pulsed Field Ablation Generator that is used with the FARAWAVE™ Pulsed Field Ablation Catheter for cardiac tissue ablation

  • Single-Shot Cryoballoon Devices (Arctic Front Advance PRO, Medtronic Inc., Minneapolis, MN, USA; POLARx and POLARx FIT Balloon Catheter, Marlborough, MA, USA)Device

    The Arctic Front Advance PRO, POLARx and FIT Balloon Catheters are CE-marked cryoablation systems consisting of a cryoballoon device, which is used in conjunction with a CryoConsole, a steerable sheath, and a circular mapping catheter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Efficacy EndpointTime frame: 0-36 months

Locations

6 sites in 5 countries. Site status is shown where the registry gives one.

  • Universitair Ziekenhuis Brussel

    Brussels, Belgium

  • Department of Cardiovascular Diseases, University Hospital Center Zagreb

    Zagreb, Croatia

  • 9. First Department of Cardiology, National and Kapodistrian University of Athens Medical School, Hippokration General Hospital

    Athens, Greece

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.